You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

55 search results for: guidelines

Emerging Therapeutic Landscape and Implications for Patient Management in PN​
expert video

Emerging Therapeutic Landscape and Implications for Patient Management in PN​

Dermatology
A review of disease burden and treatment needs in PN, and how current and emerging therapies can impact patient management.
View more
From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
expert video

From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP

Rhinology
Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP.
View more
Comparative Efficacy of Biologics for Patients with Uncontrolled and/or Severe CRSwNP
expert video

Comparative Efficacy of Biologics for Patients with Uncontrolled and/or Severe CRSwNP

Rhinology
Prof. Peter Hellings presents the comparative efficacy of biologics for patients with uncontrolled and/or severe CRSwNP.
View more
ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​
expert video

ERS 2023 | Evolving Patient Care: From Symptom Control to On-Treatment ​Clinical Remission​

Pulmonology
Join Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni for an educational program on the topic of clinical remission in severe asthma.
View more
GINA Asthma Decision Tree
videoanimation

GINA Asthma Decision Tree

Pulmonology
Walk through the GINA decision tree for severe asthma
View more
On-Treatment Asthma Remission: Moving Beyond Control
interactivity

On-Treatment Asthma Remission: Moving Beyond Control

Pulmonology
Learn about the proposed framework for clinical remission in patients with asthma
View more
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP
expert video

IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Rhinology
Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.
View more
Expert Discussion: Partnering With Patients to Improve CRSwNP Outcomes
expert video

Expert Discussion: Partnering With Patients to Improve CRSwNP Outcomes

Rhinology
Prof. Hellings discusses the importance of partnering with patients and considering the clinical importance of symptom improvements.
View more
Clinical Management of CRSwNP: Maximizing Symptom Improvement
expert video

Clinical Management of CRSwNP: Maximizing Symptom Improvement

Rhinology
Prof. Fokkens presents recent evidence of biologic effectiveness for CRSwNP from the real-world setting
View more
The Prevalence and Burden of Type 2 Inflammation in Patients With CRSwNP
expert video

The Prevalence and Burden of Type 2 Inflammation in Patients With CRSwNP

Rhinology
Dr. Stella Lee educates on the immune responses mediating CRSwNP and the prevalence of type 2 inflammation.
View more
Clinical Remission as a Goal in Asthma Clinical Practice
expert video

Clinical Remission as a Goal in Asthma Clinical Practice

Pulmonology
Profs. Alberto Papi and Ian Pavord discuss clinical remission as a goal in asthma clinical practice beyond symptom control
View more
Adult Asthma Interactive Patient Cases
interactivity

Adult Asthma Interactive Patient Cases

Pulmonology
Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MalaysiaChange country/region